CHG Dressings in Children With Central Lines

Stopped early · Not applicable

Conditions studied: Children With Central Venous Access

In brief

The purpose of this study is to determine whether Tegaderm CHG clear dressing reduces the number of unscheduled central catheter dressing changes compared to standard clear Tegaderm IV dressing in pediatric patients between the ages of 2 months to 18 years with central venous access. Secondarily, we will monitor contact skin irritation and central line associated blood stream infections.

Key facts

Study ID

NCT01955226

Run by

Yale University

People needed

16

Starts

2014-02-01

Expected to finish

2016-05-01

Last updated by the study team

2016-05-13

Who can join

Age: 0 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• All patients 2 months to 18 years of age admitted with a central venous catheter expected to be in place for > 48 hours.

You may not qualify if…

• Patients with known allergies to chlorhexidine or Tegaderm and those previously enrolled in this study will be excluded.
• Patients with portacatheters

Where it is running

• Yale University — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.